Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F19LH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,534
Award facts
- Contract value 100% obligated
- $20,534.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,534.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials. This delivery order, issued on December 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award utilizes no set-aside designation and involves competitive pricing. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency. The company's DLA Troop Support Medical contract serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, and specialized medical commodities to military healthcare systems worldwide. This delivery order for Renflexis (infliximab biosimilar) reflects the contractor's ongoing role in supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F19LH?
SPE2DR26F19LH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F19LH worth?
The government has obligated $20,534 on SPE2DR26F19LH.
Is contract SPE2DR26F19LH an order under another contract?
Yes. SPE2DR26F19LH is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F19LH competed?
The extent of competition for SPE2DR26F19LH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award